115 related articles for article (PubMed ID: 35276125)
1. Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B.
Lu Y; Zhang P; Chen H; Tong Q; Wang J; Li Q; Tian C; Yang J; Li S; Zhang Z; Yuan H; Xiang M
Toxicol Appl Pharmacol; 2022 Apr; 441():115971. PubMed ID: 35276125
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis.
Li XH; Chen XJ; Ou WB; Zhang Q; Lv ZR; Zhan Y; Ma L; Huang T; Yan YB; Zhou HM
Int J Biochem Cell Biol; 2013 May; 45(5):979-86. PubMed ID: 23416112
[TBL] [Abstract][Full Text] [Related]
3. Role of creatine shuttle in colorectal cancer cells.
Kita M; Fujiwara-Tani R; Kishi S; Mori S; Ohmori H; Nakashima C; Goto K; Sasaki T; Fujii K; Kawahara I; Bhawal UK; Luo Y; Kuniyasu H
Oncotarget; 2023 May; 14():485-501. PubMed ID: 37204253
[TBL] [Abstract][Full Text] [Related]
4. Tolerated doses in zebrafish of cytochalasins and jasplakinolide for comparison with tolerated doses in mice in the evaluation of pre-clinical activity of microfilament-directed agents in tumor model systems in vivo.
Trendowski M; Wong V; Wellington K; Hatfield S; Fondy TP
In Vivo; 2014; 28(6):1021-31. PubMed ID: 25398795
[TBL] [Abstract][Full Text] [Related]
5. Fam96b recruits brain-type creatine kinase to fuel mitotic spindle formation.
Zhang XH; Chen XJ; Yan YB
Biochim Biophys Acta Mol Cell Res; 2023 Feb; 1870(2):119410. PubMed ID: 36503010
[TBL] [Abstract][Full Text] [Related]
6. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation.
Wang Z; Hulsurkar M; Zhuo L; Xu J; Yang H; Naderinezhad S; Wang L; Zhang G; Ai N; Li L; Chang JT; Zhang S; Fazli L; Creighton CJ; Bai F; Ittmann MM; Gleave ME; Li W
Neoplasia; 2021 Nov; 23(11):1147-1165. PubMed ID: 34706306
[TBL] [Abstract][Full Text] [Related]
7. ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway.
Li F; Zhang Z; Wang P; Wen P; Xu Q; Wang Y; Pan P; Ma L
Life Sci; 2019 Sep; 232():116679. PubMed ID: 31340168
[TBL] [Abstract][Full Text] [Related]
8. Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications.
Liu W; Stachura P; Xu HC; Umesh Ganesh N; Cox F; Wang R; Lang KS; Gopalakrishnan J; Häussinger D; Homey B; Lang PA; Pandyra AA
J Exp Clin Cancer Res; 2020 Feb; 39(1):38. PubMed ID: 32085796
[TBL] [Abstract][Full Text] [Related]
9. HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy.
Krutilina RI; Playa H; Brooks DL; Schwab LP; Parke DN; Oluwalana D; Layman DR; Fan M; Johnson DL; Yue J; Smallwood H; Seagroves TN
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008190
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP
Invest New Drugs; 2015 Apr; 33(2):290-9. PubMed ID: 25563824
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anti-malignant melanoma activity of Alocasia cucullata via modulation of the phosphatase and tensin homolog/phosphoinositide 3-kinase/AKT pathway.
Fang M; Zhu D; Luo C; Li C; Zhu C; Ou J; Li H; Zhou Y; Huo C; Liu W; Peng J; Peng Q; Mo Z
J Ethnopharmacol; 2018 Mar; 213():359-365. PubMed ID: 29180042
[TBL] [Abstract][Full Text] [Related]
12. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
[TBL] [Abstract][Full Text] [Related]
14. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
Yao X; Jiang W; Yu D; Yan Z
Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
[TBL] [Abstract][Full Text] [Related]
16. PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.
Niessner H; Schmitz J; Tabatabai G; Schmid AM; Calaminus C; Sinnberg T; Weide B; Eigentler TK; Garbe C; Schittek B; Quintanilla-Fend L; Bender B; Mai M; Praetorius C; Beissert S; Schackert G; Muders MH; Meinhardt M; Baretton GB; Dummer R; Flaherty K; Pichler BJ; Kulms D; Westphal D; Meier F
Clin Cancer Res; 2016 Dec; 22(23):5818-5828. PubMed ID: 27307593
[TBL] [Abstract][Full Text] [Related]
17. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway.
Liu W; Yu Q; Wang F; Li Y; Zhang G; Tao S
Hum Exp Toxicol; 2022; 41():9603271211069034. PubMed ID: 35128947
[No Abstract] [Full Text] [Related]
18. Anticancer effects of kaempferol in A375 human malignant melanoma cells are mediated via induction of apoptosis, cell cycle arrest, inhibition of cell migration and downregulation of m-TOR/PI3K/AKT pathway.
Yang J; Xiao P; Sun J; Guo L
J BUON; 2018; 23(1):218-223. PubMed ID: 29552787
[TBL] [Abstract][Full Text] [Related]
19. Caffeic acid phenethyl ester suppresses melanoma tumor growth by inhibiting PI3K/AKT/XIAP pathway.
Pramanik KC; Kudugunti SK; Fofaria NM; Moridani MY; Srivastava SK
Carcinogenesis; 2013 Sep; 34(9):2061-70. PubMed ID: 23640046
[TBL] [Abstract][Full Text] [Related]
20. Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells.
Son S; Yoo SA; Nam K; Oh S; Lee KM; Yi JY; Shin I
Anim Cells Syst (Seoul); 2022; 26(5):203-213. PubMed ID: 36275445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
